G-quadruplex DNA: a target for drug design.
Mergny
J L
JL
Hélène
C
C
D000873:Anthracenes / Q000737:chemistry / Q000378:metabolism; D000880:Anthraquinones / Q000737:chemistry / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000138:chemical synthesis; D001483:Base Sequence; D004247:DNA / Q000737:chemistry*; D015195:Drug Design; D004355:Drug Stability; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006147:Guanine; D008956:Models, Chemical; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D010569:Perylene / Q000031:analogs & derivatives; D010880:Piperidines / Q000737:chemistry / Q000378:metabolism; D011166:Porphyrins / Q000494:pharmacology; D019098:Telomerase / Q000037:antagonists & inhibitors
D000873:Anthracenes; D000880:Anthraquinones; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; C116108:N,N'-bis(2-1(piperidino)-ethyl)-3,4,9,10-perylene-tetracarboxylic diimide; D010880:Piperidines; D011166:Porphyrins; C021096:tetra(4-N-methylpyridyl)porphine; C116107:2,6-diaminoanthraquinone; D010569:Perylene; D006147:Guanine; D004247:DNA; D019098:Telomerase